Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
| Status: | Completed |
|---|---|
| Conditions: | Migraine Headaches |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | January 2008 |
| End Date: | July 2015 |
The hypothesis of this study is that injection of botulinum toxin A into the muscles around
the head (frontal, temporal, posterior neck, occipital) can reduce the intensity and
frequency of migraine headaches by 50%.
the head (frontal, temporal, posterior neck, occipital) can reduce the intensity and
frequency of migraine headaches by 50%.
Contact PI for study details
Inclusion Criteria:
- Adults 18 and older
- Migraine for more than three months, that fail to respond to two or more major
anti-migraine drug, meeting criteria of chronic migraine
Exclusion Criteria:
- Age below 18
- Pregnant or may become pregnant
- Disease of neuromuscular junction or drugs that affect N-M junction
- Allergy to Botox
- Previous use of Botox for migraine by similar methodology
We found this trial at
1
site
Click here to add this to my saved trials
